X4 Pharmaceuticals, Inc Quarterly Goodwill in USD from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
X4 Pharmaceuticals, Inc quarterly Goodwill history and growth rate from Q4 2018 to Q3 2024.
  • X4 Pharmaceuticals, Inc Goodwill for the quarter ending September 30, 2024 was $17.4M, unchanged year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $17.4M $0 0% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $17.4M $0 0% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $17.4M $0 0% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $17.4M $0 0% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 $17.4M $0 0% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $17.4M $0 0% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $17.4M $0 0% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $17.4M $0 0% Dec 31, 2022 10-K 2024-03-21
Q3 2022 $17.4M -$9.76M -36% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $17.4M -$9.76M -36% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $17.4M -$9.76M -36% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $17.4M -$9.76M -36% Dec 31, 2021 10-K 2024-03-21
Q3 2021 $27.1M $0 0% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $27.1M $0 0% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 $27.1M $0 0% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $27.1M $0 0% Dec 31, 2020 10-K 2024-03-21
Q3 2020 $27.1M $0 0% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $27.1M $0 0% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 $27.1M -$298K -1.09% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $27.1M +$27.1M Dec 31, 2019 10-K 2021-03-19
Q3 2019 $27.1M Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $27.1M Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $27.4M Mar 31, 2019 10-Q 2019-05-15
Q4 2018 $0 Dec 31, 2018 10-K 2020-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.